YANDEX NV-A (YNDX) Fundamental Analysis & Valuation

NASDAQ:YNDX • NL0009805522

Current stock price

18.94 USD
-1.38 (-6.79%)
At close:
14.9 USD
-4.04 (-21.33%)
Pre-Market:

This YNDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. YNDX Profitability Analysis

1.1 Basic Checks

  • YNDX had positive earnings in the past year.
YNDX Yearly Net Income VS EBIT VS OCF VS FCFYNDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20B -20B 40B

1.2 Ratios

Industry RankSector Rank
ROA -3.05%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YNDX Yearly ROA, ROE, ROICYNDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 20

1.3 Margins

Industry RankSector Rank
OM -3.95%
PM (TTM) -4.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YNDX Yearly Profit, Operating, Gross MarginsYNDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

2

2. YNDX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, YNDX has more shares outstanding
  • Compared to 1 year ago, YNDX has a worse debt to assets ratio.
YNDX Yearly Shares OutstandingYNDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 100M 200M 300M
YNDX Yearly Total Debt VS Total AssetsYNDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100B 200B 300B 400B 500B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that YNDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.39 indicates that YNDX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACCN/A
WACCN/A
YNDX Yearly LT Debt VS Equity VS FCFYNDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100B 200B 300B

2.3 Liquidity

  • A Current Ratio of 1.80 indicates that YNDX should not have too much problems paying its short term obligations.
  • YNDX has a Quick Ratio of 1.71. This is a normal value and indicates that YNDX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.71
YNDX Yearly Current Assets VS Current LiabilitesYNDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50B 100B 150B 200B 250B

8

3. YNDX Growth Analysis

3.1 Past

  • The earnings per share for YNDX have decreased strongly by -161.87% in the last year.
  • YNDX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.56% yearly.
  • The Revenue has grown by 63.12% in the past year. This is a very strong growth!
  • YNDX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.22% yearly.
EPS 1Y (TTM)-161.87%
EPS 3Y-22.57%
EPS 5Y-13.56%
EPS Q2Q%-55.63%
Revenue 1Y (TTM)63.12%
Revenue growth 3Y40.78%
Revenue growth 5Y36.22%
Sales Q2Q%54.09%

3.2 Future

  • Based on estimates for the next years, YNDX will show a very strong growth in Earnings Per Share. The EPS will grow by 151.57% on average per year.
  • Based on estimates for the next years, YNDX will show a very strong growth in Revenue. The Revenue will grow by 35.03% on average per year.
EPS Next Y277.45%
EPS Next 2Y181.57%
EPS Next 3Y160.33%
EPS Next 5Y151.57%
Revenue Next Year37.74%
Revenue Next 2Y35.69%
Revenue Next 3Y34.8%
Revenue Next 5Y35.03%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
YNDX Yearly Revenue VS EstimatesYNDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T
YNDX Yearly EPS VS EstimatesYNDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200 400 600 800

2

4. YNDX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 78.92, which means the current valuation is very expensive for YNDX.
  • YNDX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.71.
  • With a Price/Forward Earnings ratio of 20.58, YNDX is valued on the expensive side.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, YNDX is valued at the same level.
Industry RankSector Rank
PE 78.92
Fwd PE 20.58
YNDX Price Earnings VS Forward Price EarningsYNDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.75
YNDX Per share dataYNDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • YNDX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • YNDX's earnings are expected to grow with 160.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y181.57%
EPS Next 3Y160.33%

0

5. YNDX Dividend Analysis

5.1 Amount

  • No dividends for YNDX!.
Industry RankSector Rank
Dividend Yield N/A

YNDX Fundamentals: All Metrics, Ratios and Statistics

YANDEX NV-A

NASDAQ:YNDX (2/25/2022, 8:19:56 PM)

Premarket: 14.9 -4.04 (-21.33%)

18.94

-1.38 (-6.79%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A
Earnings (Next)04-27
Inst Owners14.85%
Inst Owner Change-24.71%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.79B
Revenue(TTM)356.17B
Net Income(TTM)-15.71B
Analysts83.2
Price Target85.82 (353.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.92
Fwd PE 20.58
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB N/A
EV/EBITDA 33.75
EPS(TTM)0.24
EY1.27%
EPS(NY)0.92
Fwd EY4.86%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.04
BVpS8.72
TBVpSN/A
PEG (NY)0.28
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.95%
PM (TTM) -4.41%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.71
Altman-Z 2.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-161.87%
EPS 3Y-22.57%
EPS 5Y-13.56%
EPS Q2Q%-55.63%
EPS Next Y277.45%
EPS Next 2Y181.57%
EPS Next 3Y160.33%
EPS Next 5Y151.57%
Revenue 1Y (TTM)63.12%
Revenue growth 3Y40.78%
Revenue growth 5Y36.22%
Sales Q2Q%54.09%
Revenue Next Year37.74%
Revenue Next 2Y35.69%
Revenue Next 3Y34.8%
Revenue Next 5Y35.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

YANDEX NV-A / YNDX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for YANDEX NV-A?

ChartMill assigns a fundamental rating of 4 / 10 to YNDX.


Can you provide the valuation status for YANDEX NV-A?

ChartMill assigns a valuation rating of 3 / 10 to YANDEX NV-A (YNDX). This can be considered as Overvalued.


Can you provide the profitability details for YANDEX NV-A?

YANDEX NV-A (YNDX) has a profitability rating of 3 / 10.


Can you provide the financial health for YNDX stock?

The financial health rating of YANDEX NV-A (YNDX) is 4 / 10.


What is the earnings growth outlook for YANDEX NV-A?

The Earnings per Share (EPS) of YANDEX NV-A (YNDX) is expected to grow by 277.45% in the next year.